Litigation

Recent Posts

Group Sues To Stop Mosque Near New York's Ground Zero
Posted on 6 Aug 2010 by LexisNexis Litigation Resource Community Staff

NEW YORK - (AP) The debate over a planned Islamic community center and mosque near ground zero became a court fight Wednesday, as a conservative advocacy group sued to try to stop a project that has become a fulcrum for balancing religious freedom and... Read More

Lawsuits Follow Diabetes Drug Actos' Link To Cancer Risk
Posted on 9 Aug 2011 by LexisNexis Litigation Resource Community Staff

TRENTON, N.J. - (AP) The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals... Read More

Lead Attorneys In Vioxx Settlement Get $315.3M
Posted on 21 Oct 2010 by LexisNexis Litigation Resource Community Staff

NEW ORLEANS - (AP) The federal judge overseeing the thousands of lawsuits filed over withdrawn painkiller Vioxx has ruled that the lead lawyers in the case will get $315.3 million, while other lawyers who sued Merck & Co. will share $1.2 billion.... Read More

Merck To Appeal $4.6M Verdict In Massachusetts Fraud Case
Posted on 2 Oct 2010 by LexisNexis Litigation Resource Community Staff

TRENTON, N.J. - (AP) Drugmaker Merck & Co. plans to appeal a federal court verdict that a former subsidiary caused the commonwealth of Massachusetts to overpay pharmacists for a widely used asthma medication, the company said Thursday. After a three... Read More

Amylin Sues Eli Lilly Over Diabetes Drug Development Deal
Posted on 17 May 2011 by LexisNexis Litigation Resource Community Staff

INDIANAPOLIS - (AP) Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit against Eli Lilly and Co., accusing the larger drugmaker of breaking their commercialization deal for diabetes drugs by teaming with the German company Boehringer Ingelheim... Read More

Jury Awards Plaintiff $285,000 In 5th Fosamax MDL Trial But Finds No Design Defect
Posted on 5 Feb 2013 by Tom Moylan

NEW YORK - (Mealey's) A New York federal jury on Feb. 5 ordered Novartis Pharmaceuticals Corp. to pay $285,000 to a plaintiff for allegedly failing to warn her or her doctor that Fosamax carries a risk of osteonecrosis of the jaw (ONJ) ( In Re: Fosamax... Read More

Merck Wins Defense Verdict In 2nd N.J. Fosamax Jaw Injury Trial
Posted on 19 Apr 2012 by Tom Moylan

ATLANTIC CITY, N.J. - (Mealey's) A New Jersey state court jury on April 18 returned a defense verdict for Merck, Sharpe & Dohme in a Fosamax jaw injury trial, the company said in a press release ( Jo Ann Sessner v. Merck, Sharpe & Dohme, Inc... Read More

Federal Vioxx Judge Awards $315.3 Million To Core Attorney Group
Posted on 20 Oct 2010 by Michael Lefkowitz

NEW ORLEANS - (Mealey's) The judge supervising the Vioxx multidistrict litigation on Oct. 19 awarded $315.3 million to the group of attorneys who conducted discovery and other work of benefit to all federal litigants and those participating in the... Read More

Jury Returns Verdict For Plaintiffs In 1st Phase Of Contamination Trial
Posted on 2 Apr 2011 by Bill G Lowe

FRESNO, Calif. - (Mealey's) A federal jury in California on April 1 returned a verdict for the plaintiffs in the first phase of a mass tort action against the owners of an industrial site in Merced County, Calif., for allowing hexavalent chromium... Read More

Fosamax MDL Jury: Drug Wasn't Defectively Designed, Didn't Cause Jaw Injury
Posted on 3 Oct 2011 by Tom Moylan

NEW YORK - A New York federal jury hearing the fourth Fosamax bellwether trial on Oct. 3 found that Merck's osteoporosis drug was not defectively designed and did not cause a plaintiff to develop osteonecrosis of the jaw (ONJ) ( In Re: Fosamax Products... Read More

Merck Wins Defense Verdict In 1st Fosamax Femur Case To Go To Verdict
Posted on 1 May 2013 by Tom Moylan

TRENTON, N.J. - (Mealey's) A New Jersey federal jury on April 29 quickly found that Fosamax did not cause a plaintiff's femur fracture, the first verdict in a case in which a plaintiff claims that the osteoporosis drug weakened her thigh bone... Read More

Merck Settles Charges Over Vioxx Marketing For $950M, Guilty Plea
Posted on 23 Nov 2011 by LexisNexis® Mealey's™ Legal News

BOSTON - Merck, Sharp & Dohme Inc. has agreed to plead guilty to a criminal misdemeanor and to pay $950 million to resolve criminal charges and civil claims stemming from its marketing of the painkiller Vioxx a decade ago, the U.S. Department of... Read More

Tags: FDA , Vioxx , Merck

Fosamax Jaw Injury Claims Not Tolled By Class Action, Virginia Supreme Court Says
Posted on 5 Mar 2012 by Tom Moylan

RICHMOND, Va. - (Mealey's) Virginia does not recognize either equitable or statutory tolling for class actions brought by different plaintiffs in another jurisdiction, the Virginia Supreme Court ruled March 2 in an appeal by four Fosamax jaw injury... Read More

Jury Awards Plaintiff $10.4 Million For Injuries, Punitive Damages Linked To Novartis' Zometa
Posted on 5 Nov 2012 by Tom Moylan

CENTRAL ISLIP, N.Y. - (Mealey's) A New York federal jury on Nov. 2 found Novartis Pharmaceuticals Corp. liable for a woman's osteonecrosis of the jaw (ONJ) and awarded her $10.45 million, according to the parties ( Barbara Davids v. Novartis Pharmaceuticals... Read More

Jury Orders Warrick To Pay State $4.5M For Inflated Albuterol Prices
Posted on 1 Oct 2010 by Tom Moylan

BOSTON - (Mealey's) A Massachusetts federal jury on Oct. 1 ordered a defunct Merck & Co. Inc. subsidiary, Warrick Pharmaceuticals Corp., to pay $4,563,328 for causing the state to pay inflated prices for the asthma drug albuterol ( Commonwealth... Read More